MilliporeSigma has launched its new BioContinuum Platform aimed at advancing biotherapeutic drug manufacturing with improved efficiency, simplified plant operations and greater quality and consistency. The company introduced this expanded offering at PharmSci360 conference in Washington, D.C.   “MilliporeSigma’s new, adaptive platform of products, applications and expertise will allow customers to bring new therapies to patients in need, faster and more cost-effectively than ever before,” said...